[ad_1] GlaxoSmithKline's experimental drug GSK095 is designed to work with checkpoint inhibitor drugs in the hope of giving the immune system the power to launch a more aggressive attack against tumors than …
Read More »
[ad_1] The GlaxoSmithKline (GSK) logo is seen on top of GSK Asia House in Singapore, March 21, 2018. REUTERS/Loriene Perera LONDON (Reuters) – A once-monthly injection to control HIV proved as effective …
Read More »
[ad_1] LONDON – An experimental vaccine GlaxoSmithKline could prevent the development of tuberculosis in half of those who receive it, making it potentially the first vaccine against the global killer in a …
Read More »
[ad_1] LONDON (Reuters) – An experimental GlaxoSmithKline vaccine could prevent the development of TB in half of the cases, potentially making it the first vaccine against the global killer in a century, …
Read More »